ILC Therapeutics raises £3.5m to advance lead interferon drug candidate
UK-based biotech company ILC Therapeutics has announced the successful completion of a £3.5m pre-IPO funding round.
In a statement, ILC Therapeutics – which is fo...
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingExploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingExploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingHighlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement